A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions

Inflammatory Disease

Interventions

DRUG

amilo-5MER

amilo-5MER is a 5 amino acid synthetic peptide MTADV (Methionine, Threonine, Alanine, Aspartic acid, Valine).

Trial Locations (1)

Quotient Sciences, Mere Way, Ruddington, Nottingham, NG11 6JS, UK, Nottingham